ST. LOUIS, Feb. 19, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will release financial results for its 2013 fourth quarter and full year ended December 31, 2013 on Tuesday, February 25, 2014 after the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the Company's results and corporate developments.
|What:||Stereotaxis fourth quarter and full year 2013 financial results conference call|
|When:||Tuesday, February 25 th at 4:30 p.m. Eastern Time (1:30 p.m. PT)|
|Dial In Number:||877-941-1427 (US and Canada)|
|Webcast:||To access the live and replay webcast, please visit the investor relations section of Stereotaxis'|
|website at www.stereotaxis.com|
|Call Replay:||A replay of the call will be available approximately one hour following the end of the call|
|through 11:59 p.m. ET on Tuesday, March 4, 2014.|
|Replay Numbers:||800-406-7325 (US and Canada)|
|Replay passcode: 4670284#|
Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core Epoch™ Solution includes the Niobe® ES Remote Magnetic Navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts